We are live on ! Find out more
MEDP icon

Medpace

337 hedge funds and large institutions have $5.42B invested in Medpace in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 139 increasing their positions, 116 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

48% more call options, than puts

Call options by funds: $25.2M | Put options by funds: $17M

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

20% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 116

11% more capital invested

Capital invested by funds: $4.87B → $5.42B (+$546M)

4% more funds holding

Funds holding: 324337 (+13)

3.17% more ownership

Funds ownership: 76.73%79.91% (+3.2%)

Holders
337
Holders Change
+13
Holders Change %
+4.01%
% of All Funds
5.9%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
37
Increased
139
Reduced
116
Closed
20
Calls
$25.2M
Puts
$17M
Net Calls
+$8.16M
Net Calls Change
+$1.54M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$711M +$6.92M +37,926 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$599M -$11.1M -60,738 -2%
WA
3
Wasatch Advisors
Utah
$472M +$8.53M +46,770 +2%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$216M +$179M +980,774 +603%
Invesco
5
Invesco
Georgia
$176M +$110K +602 +0.1%
State Street
6
State Street
Massachusetts
$164M +$2.86M +15,688 +2%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$124M +$2.47M +13,524 +2%
ESCM
8
Echo Street Capital Management
New York
$120M +$31.5M +172,558 +37%
BTW
9
Boston Trust Walden
Massachusetts
$100M +$395K +2,164 +0.4%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$99.8M +$1.07M +5,845 +1%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$97.1M -$34.6M -189,782 -27%
Fuller & Thaler Asset Management
12
Fuller & Thaler Asset Management
California
$90.9M +$11.9M +65,218 +16%
Northern Trust
13
Northern Trust
Illinois
$82.5M -$1.24M -6,793 -2%
Renaissance Technologies
14
Renaissance Technologies
New York
$78.3M -$1.53M -8,400 -2%
GKIM
15
GW&K Investment Management
Massachusetts
$74.5M -$285K -1,560 -0.4%
ACM
16
American Capital Management
New York
$73.1M +$5.25M +28,794 +8%
RIM
17
Ranger Investment Management
Texas
$62.6M -$1.63M -8,955 -3%
Fisher Asset Management
18
Fisher Asset Management
Washington
$62.1M +$6.44M +35,282 +12%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$61.9M +$1.7M +9,324 +3%
Ameriprise
20
Ameriprise
Minnesota
$58.9M +$15.7K +86 +0%
VVP
21
Vulcan Value Partners
Alabama
$58.4M +$15.2M +83,328 +37%
RP
22
Riverbridge Partners
Minnesota
$55.4M -$631K -3,459 -1%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$54.7M +$2.64M +14,457 +5%
Charles Schwab
24
Charles Schwab
California
$52.7M +$3.09M +16,953 +6%
Norges Bank
25
Norges Bank
Norway
$48.9M -$2.37M -12,967 -5%

MEDP Hedge Fund Activity: Q3 2021 in Review

337 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2021, worth a combined $5.42B — up 11% from $4.87B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MEDP positions and 20 closed out — a net gain of 17 holders — while 139 added to existing stakes and 116 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $179M. The largest seller was Pendal Group, cutting an estimated $115M.

  • 337 institutional investors held Medpace (MEDP) as of Q3 2021, up from 324 in Q2 2021.
  • Funds reported $5.42B of Medpace stock for Q3 2021, up 11% quarter-over-quarter.
  • 37 funds opened new Medpace positions in Q3 2021 and 20 closed out, a net change of +17 holders.
  • The largest Medpace buyer in Q3 2021 was Wellington Management Group, an estimated $179M added.
  • The largest Medpace seller in Q3 2021 was Pendal Group, an estimated $115M sold.

Based on aggregated 13F filings for Q3 2021.